To meet the evolving customer demands in healthcare, NEC will now focus its development efforts and resources in key business areas, including clinical review, administration and back office, information way-finding, digital signage, education and conferencing. NEC will continue to bring display innovations to its professional healthcare product portfolio. Its non-diagnostic display partners and OEMs are not affected by NEC’s transition.
“While discontinuing future development in the medical diagnostic display market is a difficult decision, we are determined that now is the appropriate time to accelerate innovation in the markets where we deliver the greatest benefits and highest value,” said Todd Bouman, President and CEO of NEC Display. “We are thankful for our valued diagnostic display customers and remain committed to seeing them through this transition.”
The company will continue to support all diagnostic products sold through their warranty periods, including any updates to GammaCompMD QA software. For North American customers, the period is five years from the date of sale and includes Advanced Overnight Exchange Warranty.
NEC Display’s commitment to product innovation, market growth, channel development and its solutions strategy is stronger than ever. The NEC healthcare portfolio enables NEC’s partners to develop the perfect combinations of products and services for their clients. These solutions are backed by NEC Display’s reliability, and industry-leading services and support capabilities.
For more information, please visit NEC Display on the web.
